Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Mar 25;22(1):90.
doi: 10.1186/s12906-022-03571-8.

In vitro antibacterial and cytotoxic effects of Euphorbia grandicornis Blanc chemical constituents

Affiliations

In vitro antibacterial and cytotoxic effects of Euphorbia grandicornis Blanc chemical constituents

Douglas Kemboi et al. BMC Complement Med Ther. .

Abstract

Background: Euphorbia grandicornis is widely utilized in traditional medicine for the treatment of microbial infections including sexually transmitted diseases such as syphilis, gonorrhoea and for healing of wounds.

Objective: The aim of this work was to isolate and evaluate the antibacterial and anticancer activities of Euphorbia grandicornis chemical constituents.

Methods: Chemical constituents were isolated and identified using various spectroscopic techniques such as IR, MS, and NMR. The single point growth inhibitory potential of the compounds was determined using a 96-well plate based assay.

Results: The CH2Cl2 crude extracts exhibited potent antibacterial activity against Escherichia coli ATCC 8739 and Staphylococcus aureus ATCC 6538 with percentage growth of 94.90 ± 4.24 and 29.47 ± 4.89 respectively. Hence, the CH2Cl2 crude extract was further subjected to column chromatography which resulted in the isolation of methyl 2,5-dihydroxybenzoate (1), n-octyl benzoate (2), friedelanol (3), and germanicol (4) and identification of compounds 12-24 for the first time in the species based on the LC-MS/MS spectroscopic data. The purified compounds (1-4), and previously reported compounds (5-11) were evaluated for antibacterial activities against S. aureus and E. coli, as well as the cytotoxicity effects against HeLa cells. Of the purified compounds, methyl 2,5-dihydroxybenzoate (1), was the most active against E.coli and S. aureus with a percentage growth of 19.12 ± 0.65 and 23.32 ± 0.23 respectively. β-amyrin (6), and β-sitosterol (8), were active against S. aureus with percentage growth of 27.17 ± 0.07, and 47.79 ± 2.99 respectively.

Conclusion: The results obtained from this study indicate that E. grandicornis, is a rich source of chemical constituents that may provide new lead compounds for the development of antibacterial agents.

Keywords: Chemical constituents; Euphorbia grandicornis; Staphylococcus aureus ATCC 6538 and Escherichia coli ATCC 8739.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Fig. 1
Fig. 1
Chemical structures of isolated compounds from E. grandicornis Blanc
Fig. 2
Fig. 2
Structures of identified compounds from Euphorbia grandicornis Blanc crude extracts by LC-MS/MS
Fig. 3
Fig. 3
Percentage growth of S. aureus, E. coli and Hela cells

References

    1. Theuretzbacher U, Mouton JW. Update on antibacterial and antifungal drugs - can we master the resistance crisis? Curr Opin Pharmacol. 2011;11:429–432. doi: 10.1016/j.coph.2011.08.002. - DOI - PubMed
    1. Walsh TR, Toleman MA. The emergence of pan-resistant gram-negative pathogens merits a rapid global political response. J Antimicrob Chemother. 2012;67:1–3. doi: 10.1093/jac/dkr378. - DOI - PubMed
    1. Awouafack MD, Mcgaw LJ, Gottfried S, Mbouangouere R, Tane P, Spiteller M, et al. Antimicrobial activity and cytotoxicity of the ethanol extract, fractions, and eight compounds isolated from Eriosema robustum (Fabaceae). BMC Complement Altern Med. 2013;13 10.1186/1472-6882-13-289. - PMC - PubMed
    1. Srivastava J, Chandra H, Nautiyal AR, Kalra SJS. Antimicrobial resistance (AMR) and plant-derived antimicrobials (PDAms) as an alternative drug line to control infections. Biotech. 2014;4:451–460. - PMC - PubMed
    1. Levin S. The crisis in antibiotic resistance. Infect Dis Clin Pract. 1993;2:53. doi: 10.1097/00019048-199307000-00013. - DOI

LinkOut - more resources